---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-037567"
form_type: "8-K"
ticker: "VCEL"
cik: "0000887359"
company_name: "Vericel Corp"
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T12:31:51.335518+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vericel reports Q3 2023 revenue of $45.6M (+18% YoY), raises FY guidance

## Summary
- Total revenue $45.6M (+18% YoY); MACI revenue $37.6M (+21% YoY).
- Net loss $3.7M ($0.08/sh); adjusted EBITDA $5.4M (12% of revenue).
- FY2023 revenue guidance raised to $192.5-197.5M from prior $190-197M.
- Cash $149M, no debt; 13th consecutive quarter of positive adjusted EBITDA and operating cash flow.
- MACI arthroscopic delivery launch expected H1 2024; NexoBrid commercially launched.

## SEC filing metadata
- accession: 0001628280-23-037567
- form_type: 8-K
- ticker: VCEL
- cik: 0000887359
- company_name: Vericel Corp
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887359/000162828023037567/0001628280-23-037567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887359/000162828023037567/vcel-20231108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-037567
- JSON: https://secwatch.observer/filing/0001628280-23-037567.json
- Plain text: https://secwatch.observer/filing/0001628280-23-037567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.